Annual Meeting & Reports

Changes in Irish accounting regulations require the Company to adopt a new accounting framework for its parent entity Irish statutory financial statements for the financial year ended April 29, 2016. We consider it to be in the best interests of the Company to adopt FRS 102 (The Financial Reporting Standard Applicable in the U.K. and Republic of Ireland) for the financial year ended April 29, 2016. The Company intends to utilize the disclosure exemptions available. No disclosures in the consolidated U.S. GAAP financial statements would be omitted on adoption of FRS 102 by the parent entity for its Irish statutory financial statements. A shareholder or shareholders having an aggregate holding of 5% or more of the total outstanding ordinary shares in the Company may serve objections in writing to the use of the disclosure exemptions to the Company Secretary at Medtronic plc, 20 On Hatch, Lower Hatch Street, Dublin 2, Ireland before midday, Irish Time on September 1, 2016.